Expanded Genetic Code Technology Platform
We incorporate synthetic amino acids into proteins within living cells. The result? Product candidates designed for highly stable, site-specific conjugation, overcoming the inherent limitations of conventional conjugation approaches.
Focused Oncology Portfolio
We are advancing enhanced antibody drug conjugates and other engineered therapies to modulate the immune system as potential treatments for various cancer indications.